Bristol Myers Squibb Announces Topline Results Showing Treatment with Orencia Improved Survival in People Hospitalized with COVID-19 Pharmaceutical Investing
Gilead Sciences Appoints Stacey Ma, PhD as Executive Vice President, Pharmaceutical Development and Manufacturing Pharmaceutical Investing
Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs Pharmaceutical Investing
Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE® Life Science Investing
AbbVie Presents Positive Results from Phase 3 SELECT-AXIS 2 Trials of Upadacitinib in Patients with Axial Spondyloarthritis at EULAR 2022 Pharmaceutical Investing
Late-Breaking Data at EULAR 2022 Demonstrate Deucravacitinib Significantly Improved Disease Activity in Phase 2 PAISLEY Study in Systemic Lupus Erythematosus Pharmaceutical Investing
Jamieson Wellness Inc. to Acquire Nutrawise Health & Beauty Corporation, Owner of youtheory Brand Life Science Investing
